Important information and resources have been developed to help healthcare professionals, clinical leads and managers understand and implement the new safety measures for isotretinoin prescribing (including patient information resources).
See links in the documentation section.
The Area Prescribing Committee recommends the use of oral isotretinoin for the treatment of severe acne resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy.
Isotretinoin will be considered RED with prescribing limited to or under the supervision of physicians with expertise in the use of systemic retinoids for severe acne and a full understanding of the risks and monitoring requirements.
For important information and resources related to Pregnancy Prevention Programme and neuropsychiatric disorders are available on PAD
